Financial Services

How one firm's deep investment in local associations and talent development is shaping the future of the Southeast's booming multifamily housing market.

Nodal Exchange's record January highlights booming demand for energy and carbon derivatives as the green transition accelerates market volatility and risk.

Upexi's new funding bolsters its ambitious Solana treasury, but the deal's terms, including warrant adjustments, raise dilution concerns for investors.

The fragrance giant affirmed its $0.20 quarterly dividend, signaling stability to investors even as it navigates shifting consumer habits and a tough market.

CR Fitness Holdings announces a 43,000 sq ft Crunch gym in Maitland, signaling a major move in Central Florida's competitive fitness market.

Australian biotech Immutep reaches a key milestone in its Phase III trial for a novel lung cancer therapy, a major step in a multi-billion dollar market.

For the 12th straight year, Operation HOPE earns top marks for transparency and results. Here's what that means for the communities it serves.

The warehouse club operator signals robust confidence with a major dividend hike and plans for four new stores, pushing its stock to near-record highs.

With a major mine online in Korea and a new US acquisition, Almonty Industries is poised to break China's tungsten monopoly amid record prices.

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.

Karat Packaging rewards investors with a $0.45 quarterly dividend, but can the high-yield payout be sustained amid rising costs and shrinking margins?

Emirates Flight Catering's massive new biodigester system from Power Knot processes tonnes of daily food waste, setting a new sustainability standard.

With its stock soaring, AGF Management renews its buyback plan to repurchase 10% of its public float, a strategic move to boost value and manage dilution.

With rapid trial enrollment for a novel drug, Pulmovant offers a potential lifeline for patients with PH-ILD, a condition with few to no options.

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

Indonesian forestry giant APP Group holds its 'B' score in a key environmental audit. What does this mean for sustainability in a high-stakes industry?

Hong Kong's newest attraction isn't just a bounce house—it's a record-breaking event celebrating community, health, and a major corporate milestone.

The Nutella maker posts strong growth, but its acquisitions of Kellogg's cereals and Power Crunch signal a bold new strategy beyond confectionery.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

China's top pig farmer, Muyuan Foods, raises HK$10.7B in a landmark Hong Kong IPO, fueling a high-tech global expansion into Southeast Asia and beyond.